Accession Number : AD1007071


Title :   DARPA Antibody Technology Program Standardized Test Bed for Antibody Characterization: Characterization of an MS2 ScFv Antibody


Descriptive Note : Technical Report,01 Oct 2010,01 Sep 2012


Corporate Author : Army Edgewood Chemical Biological Center Aperdeen Proving Ground


Personal Author(s) : Buckley,Patricia E ; Calm,Alena M ; Welsh,Heather S ; Thompson,Roy ; Kim,Michael H ; Kragl,Frank J ; Carney,James ; Warner,Candice ; Zacharko,Melody


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/1007071.pdf


Report Date : 01 Mar 2016


Pagination or Media Count : 30


Abstract : The selection of antibodies for inclusion in a final assay format has primarily relied on an antibodys performance in an enzyme-linked immunosorbent assay (ELISA), with little regard for quantification of the full spectrum of variables affecting antibodyantigen interactions. The Joint Product Management Office for Biosurveillance (JPMO BSV) Critical Reagents Program has recently instituted a quality program for standardization of test methods to support more comprehensive characterization and comparison of the physical and functional properties of antibody reagents within its repository. The development and standardization of antibody testing provides JPMO BSV with an invaluable platform for the provision of consistent, high-quality assays and reagents for current biodetection platforms as well as the development and validation of future systems. This platform will be used to characterize the MS2 recombinant antibody produced at U.S. Army Edgewood Chemical Biological Center for the Defense Advanced Research Projects Agency (DARPA) Antibody Technology Program (ATP).


Descriptors :   surface plasmon resonance , antibodies , proteins , enzymes , Immunoassay , phosphoric acids , test methods , Electrophoresis , Cultures (Biology) , cells (biology) , thermal stability , biological detection , biological agents , exposure (physiology) , antigens


Distribution Statement : APPROVED FOR PUBLIC RELEASE